SynchroMed™ III Implantable infusion system

SynchroMed™ III is an implantable targeted drug infusion system that helps manage chronic pain, cancer pain, and severe spasticity.

Simple, safe and effective intrathecal therapy made possible

Unlike medications that must be absorbed systemically and must cross the blood-brain barrier, an implanted SynchroMed™ III programmable pump and catheter deliver prescribed amounts of medication directly into the intrathecal space.

Targeted drug delivery (TDD) into the intrathecal space offers effective relief at a fraction of the systemic dose, which can reduce side effects.1-3

The SynchroMed™ III implantable infusion system provides:

  • State-of-the-art pump electronics to enable enhanced long-term reliability and wireless firmware upgradability to facilitate expanded capabilities
  • End-to-end cybersecurity controls for enhanced patient data protection
  • Refill-only workflow, which enables a shorter and more consistent update duration during this common clinician device interaction
  • Continued peace of mind with proven durable design enhancements built into the SynchroMed™ II pump, which have increased pump survival rate to 99%.*